Clinical Trials
Pursuing clinical validation of a new class of endocannabinoid system-targeting medicines
Skye Bioscience is committed to applying best practices from drug design through manufacturing, preclinical and clinical development, and regulatory review. Our ambition is to clinically validate promising drug candidates that interact with the endocannabinoid system to potentially address various diseases